Markets and Markets, Dec 2010, Pages: 378
therapies and drugs, and increase in population aged 65 years and above. From 2009 to 2016 the U.S. market revenues are forecast to grow at a compound annual growthrate (CAGR) of 11
Decision Resources, Inc., Oct 2011
: packaging, formulations, full-scale manufacturing?
Scope:
Biologics: Recombinant proteins, monoclonal antibodies (MAbs), size and growthrate of technology sectors in the global pharmaceutical
Decision Resources, Inc., Aug 2011
Introduction to the vaccine market: Market size, market growth, market drivers, product sales, unmet needs.
Primary research: Results from a February 2011 Web-based survey of 106 U.S. physicians who administer
TriMark Publications, May 2010, Pages: 301
.5: Generics vs. Branded Animal Health Pharmaceuticals, 2010
Table 7.6: U.S. Animal Health Generic Pharmaceuticals in the Pipeline, 2010
Table 7.7: Veterinary Insurance Rates and Coverage for Dogs in the U
Decision Resources, Inc., Nov 2011
prices: drug price inflation; rebate trends.
- Pharmaceutical market trends: market size and growthrates; declining uptake of new drugs; accelerating rate of generic erosion; shifts in patterns
Venture Planning Group, Oct 2010, Pages: 1200
AND MARKET SHARES
VIII. U.K.
A. EXECUTIVE SUMMARY
B. BUSINESS ENVIRONMENT
C. MARKET STRUCTURE
D. MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES, INSTRUMENT PLACEMENTS AND MARKET SHARES
IX.U.S.A.
A. EXECUTIVE
Nutrition Business Journal, Dec 2009, Pages: 486
.
- While the total U.S. consumer supplement market grew 6.2% in 2008 to $25.2 billion, sales of raw materials and ingredients used in supplement increased by 9.2% to $2.9 billion. This is the highest growth
Markets and Markets, Jan 2012, Pages: 454
BBS Healthcare (U.S.), Omega Healthcare (India), and Inventive (U.S.). The pharmaceutical outsourcing market is captured by players such as Quintiles (U.S.), Covance (U.S.), PPD (U.S.), Parexel (U.S.), Charles
Frost & Sullivan, Feb 2004
Award
3. Technology Leadership Award
4. Market Penetration Leadership Award
4. U.S. Carbon-Carbon Bond Forming Pharmaceutical Intermediates Market
1. Overall
Global Markets Direct, Nov 2011, Pages: 107
of Ophthalmology Meeting
Mar 09, 2010: Ista Receives Action Date For FDA Review Of Once-Daily XiDay
Mar 09, 2004: ISTA Pharmaceuticals Announces Positive Results From Xibrom U.S. Phase III Trials; Conference
iData Research, Oct 2010, Pages: 202
Chart 3-3: Total Cosmetic Surgery, Facial Aesthetics and Medical Laser Device Market by Segment, U.S., 2017
Chart 3-4: GrowthRates by Segment, Cosmetic Surgery, Facial Aesthetics and Medical Laser
Decision Resources, Inc., Jan 2008, Pages: 30
, while the Japanese government seemingly changed course on overhauling its pharmaceutical pricing and reimbursement system.
Get the Answers You Need to Shape Your Strategy
- Pending U.S. legislation
Nutrition Business Journal, Aug 2007, Pages: 723
SUBCATEGORY, 1998-2010E
FIGURE 2-34 U.S. HEALTHY FOOD CATEGORY SALES GROWTH BY PRODUCT SUBCATEGORY, 1998-2010E
FIGURE 2-35 PENETRATION RATE OF U.S. HEALTHY FOOD AS A PERCENTAGE OF TOTAL U.S. FOOD SALES 1997
TriMark Publications, Oct 2010, Pages: 243
.1: Leading Causes of Death in the U.S., 1961-2007
Figure 1.2: Global Distribution of Anti-Infective Drugs Sales by Geography
Figure 2.1: Incidence Rates of Invasive MRSA Infections by Age
Figure 2.2: U.S
Markets and Markets, Dec 2011, Pages: 148
designation grant from U.S. FDA and European Union. Besides, the drug has obtained fast track designation in the United States in 2010 for the treatment of FLT3-ITD positive patients with relapsed/refractory
Decision Resources, Inc., June 2011
survey of 106 U.S. physicians who administer infectious disease vaccines: infectious disease specialists, pediatricians, and primary care physicians (PCPs).
Market size: Worldwide and U.S. market size
Markets and Markets, Nov 2011, Pages: 286
market-
- Angiogenesis inhibitor - lanreotide, TASQ, Zaltrap
- Apoptosis inducing - custirsen sodium
- Signal transduction inhibitor - Sprycel
The geographies covered under the report are -
- North America
- U.S
Decision Resources, Inc., Feb 2009, Pages: 35
window.
- Impact on the pharma industry: credit crunch, layoffs at the top 13 pharma companies, impact of unemployment on healthcare; 2008 pharma sales through retail pharmacies; size and growthrate
Markets and Markets, Dec 2011, Pages: 345
The Development in the High Potency Active Pharmaceutical Ingredient (HPAPI) and Biogeneric drugs is boosting the growth of the Active Pharmaceutical Ingredient (API) market. There has been
